GLUCOSYLCERAMIDSYNTHASE-INHIBITORER
The invention relates to inhibitors of glucosylceramide synthase (GCS) of formula (I) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, cystic disease and for the treatment of cancer.
Saved in:
Main Authors | , , , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | Danish |
Published |
09.05.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to inhibitors of glucosylceramide synthase (GCS) of formula (I) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, cystic disease and for the treatment of cancer. |
---|---|
Bibliography: | Application Number: DK20130765893T |